Literature DB >> 19579633

Role of CT in detecting malignancy during follow-up of patients with branch-type IPMN of the pancreas.

Satoshi Hirano1, Satoshi Kondo, Eiichi Tanaka, Toshiaki Shichinohe, On Suzuki, Michio Shimizu, Tomoo Itoh.   

Abstract

BACKGROUND/AIMS: This retrospective study evaluated the suitability of computed tomography (CT) to detect malignancy while following patients with branch-type IPMN, most of which are benign and may be treated with observation alone.
METHODOLOGY: Forty-two surgical specimens resected from patients with a diagnosis of branch-type IPMN were pathologically classified as benign (n=26), which included hyperplasia and adenoma, or malignant (n=16), including moderate dysplasia or adenocarcinoma. It was compared the differences in the sizes of the tumor and main pancreatic duct (MPD) and the presence of mural nodules on CT between the groups.
RESULTS: In the malignant group, it was observed a larger tumor size (47.8 vs. 23.8 mm; p = 0.001) and increased dilation of the MPD (9.3 vs. 5.0 mm; p = 0.001) than those seen in the benign group. The accuracy of CT diagnosis of mural nodules, however, was only 62%. Tumor diameter > or =40 mm or MPD diameter >10 mm predicted malignancy with a sensitivity and negative predictive value of 93.8% and 95.7%, respectively.
CONCLUSIONS: Either tumor size or MPD dilation detected by CT could predict the majority of malignant branch-type IPMNs. Increases in these morphological characteristics on CT images during the follow-up period would be an accurate method to predict a diagnosis of malignancy.

Entities:  

Mesh:

Year:  2009        PMID: 19579633

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  4 in total

1.  Computed tomography reflected endocrine function of the pancreas.

Authors:  Naoaki Sakata; Shinichi Egawa; Toshiki Rikiyama; Gumpei Yoshimatsu; Kunihiro Masuda; Hideo Ohtsuka; Shigeru Ottomo; Kei Nakagawa; Hiroki Hayashi; Takanori Morikawa; Tohru Onogawa; Kuniharu Yamamoto; Hiroshi Yoshida; Masanori Akada; Fuyuhiko Motoi; Takeshi Naitoh; Yu Katayose; Michiaki Unno
Journal:  J Gastrointest Surg       Date:  2010-12-23       Impact factor: 3.452

2.  Imaging considerations in intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Ivan Pedrosa; Dennis Boparai
Journal:  World J Gastrointest Surg       Date:  2010-10-27

3.  Current recommendations for surveillance and surgery of intraductal papillary mucinous neoplasms may overlook some patients with cancer.

Authors:  Andrew H Nguyen; Paul A Toste; James J Farrell; Barbara M Clerkin; Jennifer Williams; V Raman Muthusamy; Rabindra R Watson; James S Tomlinson; O Joe Hines; Howard A Reber; Timothy R Donahue
Journal:  J Gastrointest Surg       Date:  2014-11-06       Impact factor: 3.452

4.  Predictors of Malignancy in "Pure" Branch-Duct Intraductal Papillary Mucinous Neoplasm of the Pancreas without Enhancing Mural Nodules on CT Imaging: A Nationwide Multicenter Study.

Authors:  Tae-Hyeon Kim; Young-Sik Woo; Hyung-Ku Chon; Jin-Hyeok Hwang; Kyo-Sang Yoo; Woo-Jin Lee; Kwang-Hyuck Lee; Jong-Kyun Lee; Seok-Ho Dong; Chang-Hwan Park; Eun-Taek Park; Jong-Ho Moon; Ho-Gak Kim; Kwang-Bum Cho; Hong-Ja Kim; Seung-Ok Lee; Young-Koog Cheon; Jeong-Mi Lee; Jin-Woo Park; Myung-Hwan Kim
Journal:  Gut Liver       Date:  2018-09-15       Impact factor: 4.519

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.